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Abstract: 
Humans are exposed to a large number of contaminants, many of which may have similar 
health effects. This paper presents a framework for identifying pollutants to be included in a 
cumulative risk assessment approach. To account for the possibility of simultaneous exposure 
to chemicals with common toxic modes of action, the first step of the traditional risk 
assessment process, i.e. hazard identification, is structured in three sub-steps: 1a) 
Identification of pollutants people are exposed to, 1b) Identification of effects and 
mechanisms of action of these pollutants, 1c) Grouping of pollutants according to similarity 
of their mechanism of action and health effects. Based on this exposure-based grouping we 
can derive “multi-pollutant” toxicity reference values, in the “dose-response assessment” 
step. The approach proposed in this work is original in that it is based on real exposures 
instead of a limited number of pollutants from a unique chemical family, as traditionally 
performed. This framework is illustrated by the case study of semi-volatile organic 
compounds in French dwellings, providing insights into practical considerations regarding 
the accuracy of the available toxicological information. This case study illustrates the value 
of the exposure-based approach as opposed to the traditional cumulative framework, in 
whichchemicals with similar health effects were not always included in the same chemical 
class. 
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1. Introduction 
Human beings use many chemicals in various circumstances, such as: manufacturing and use 
of products and articles, industrial processing, agriculture, etc. These chemicals and their by-
products are likely to be found in the environment and are the source of diffuse and multiple 
contaminations of the different compartments: pesticides in soils, water, diet or air, persistent 
organic pollutants in the food chain, urban air pollution, volatileand semi-volatile organic 
compounds in indoor and outdoor environments, etc. As a consequence, human beings 
areexposed throughoral, respiratory or dermal routesto a large variety of chemicalspresent in 
food, air, water and dust, generally at low doses.The presence of such pollutantsand their 
metabolites in human biological fluids has confirmed this hypothesis. For example, the 
National Health and Nutrition Examination Survey – designed to assess the health and 
nutritional status of adults and children in the United States – included biomonitoring 
surveysthat showed the presence of detectable levels of a large variety of chemicals and their 
metabolites in blood or urine of human people, such as metals, phthalates or pesticides’ 
metabolites (NHANES, 2013). 
Regulations related to the chemicals entering in European market, both for domestic and 
professional uses, are based on risk assessment and management (European Union, 2009, 
2006). However, the laws on the use of chemicals (cosmetics, biocides, pesticides, medicines, 
food additives and more) do not allow a comprehensive and global risk analysis. Standard 
toxicological tools, in particular studies on laboratory mammals, are not suitable forstudying 
the effects induced by complex and low-dose chemical mixtures. Little knowledge is 
routinely generated on the hazards of these chemical mixtures. The real impact of dietary and 
environmentalcontamination is not known and therefore not fully taken into account in public 
health decisions. The implementation of cumulative risk assessment strategies for complex 
mixtures is therefore of high concern as statedby Sarigiannis and Hansen (Sarigiannis and 
Hansen, 2012). 
Avariety ofcumulative risk assessment (CRA) methodologies have already been suggested to 
improve risk management decision-making. For example, toxic equivalent factors have been 
definedfor dioxins, furans, dioxin-like polychlorinated biphenyls (PCB-dl)andpolycyclic 
aromatic hydrocarbons (PAHs), on the basis of their ability to bind the Aryl hydrocarbon 
Receptor (Safe, 1990; Van den Berg et al., 2006, 1998). Similarly, the U.S. Environmental 
Protection Agencysuggestedusing an approach based onrelative potency factors(RPF) for 
organophosphate and carbamatepesticides on the basis oftheir ability to inhibit the 
acetylcholinesterase enzyme (US EPA, 2006, 2002). More recently, theseapproacheswere 
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extended to other molecules, such as pyrethroid pesticides (Wolansky et al., 2005)and 
phthalates(Hannas et al., 2011). However, these approaches generally take into account only 
one chemical family. Taking into account pollutantsfrom different chemical familieswould 
undoubtedly better reflect actualenvironmental human exposures.This issue was first 
addressed by Kortenkamp and co-workerswho proposed a CRAbased on the anti-androgenic 
abilities of 15 substances including pesticides (fungicides, insecticides), as well asphthalates, 
brominated compounds and parabens(Kortenkamp and Faust, 2010). The hazard index 
method was then chosen to afford more flexibility in dealing with various data quality issues 
by using varying uncertainty factors. However, the use of different critical doses(no observed 
adverse effect level versus lowest observed adverse effect level for example)led to difficulties 
in the interpretation of results. In addition, this pioneeringstudy was based on the mechanism 
of toxicity of substances that people are not typicallyexposed to.It seems therefore necessary 
to pursue the improvement of the CRA methodology.  
The objective of this work is to propose an additional step in theCRA approach, based on 
grouping pollutants people are actually exposed to. Only the threshold method will be 
developed (for non-carcinogenic or non-genotoxic compounds). We illustrate this exposure-
based CRA framework with a case study based on exposure to Semi Volatile Organic 
Compounds (SVOCs) in French indoor environments. 
 
2. A brief review of cumulative risk assessment methods 
The risk assessment process was initially defined by the NRC in 1983 (National Research 
Council U.S. Committee on the Institutional Means for Assessment of Risks to Public 1983). 
In the traditional approach, four steps are used and described as follows: 1) Hazard 
identification, to determine whether a chemical is linked to one or morespecific health 
effects, 2) Dose-response assessment, to identify the relation between the magnitude of 
exposure and the likelihoodor occurrence of health effects in a population. In its simplest 
form, this step is the choice of a toxicity reference value (a reference dose for 
example)according to an exposure route and duration, 3) Exposure assessment, to determine 
the extent and the magnitude of human exposure, and 4) Risk characterization, to describe the 
nature and magnitude of human health risk, including uncertainties. This last step is the 
combination of the previous ones. It generally compares the estimated human exposure with 
the selected toxicity reference value. It results in a hazard quotient (Exposure / toxicity 
reference value) if the threshold assumption is used, or an excess risk (Exposure × toxicity 
reference value) in the case of a non-threshold assumption. 
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A dose-additivity assumption has been used for forty years (Sprague 1970)in the cumulative 
risk assessment process, where a threshold hypothesis is used. The simplest approach is to 
sum the hazard quotientobtained for each chemical (US EPA, 2000, 1986)to obtain a hazard 
index. The main limitation is the lack of comparability of the ratio obtained for each pollutant 
when, for example, the reference doses are not defined based on the same critical effect. This 
method could be used to identify the chemical of most concern in the mixture but 
cannotpredict the effect of the mixture. This method takes into account the most sensitive 
critical effect induced by each pollutant. The risk could be considered as negligiblewhen the 
hazard index is less thanone. If not, a more in-depth approach should be used. An 
improvement of this approach was proposedusingthe point of departure index which directly 
comparesthe exposure to a critical dose, or “point of departure”, in which the same effect is 
selected for all substances,even if the point of departures are different:no observed adverse 
effect level, lowest observed adverse effect levelor benchmark dose). The point of departure 
indexis then compared to human exposure, leading to a margin of exposure that is 
interpretedkeeping in mind theuncertainties ofthe toxicological data used to derive the point 
of departure.Another approach is directly derived and extrapolatedfrom the toxic equivalent 
factor for dioxins, furans,PCB-dl and PAHs, based on their affinity to the arylhydrocarbon 
receptor. The RPF approach first described by the US EPA(US EPA, 2002)is based on the 
assumptions of a similar mechanism / mode of action and parallel dose-response curves. The 
toxic potency of each chemical is normalized relative to the best-known compound. These 
RPFs can be constructed by comparingthe toxicity indicators (benchmark doses based on the 
same mechanism for example, or an effective dose corresponding to a percentage of response 
or affinity). They are then used to weight the exposure of the different compounds,then added 
together to determine ahazard quotientbased on the toxicity reference valueof the index 
compound. This approach requires more accurate mechanistic information and can therefore 
be applied only to the most widely studied pollutants.Several reviews with a more in depth 
description of these approaches are available (Kortenkamp and Faust 2010; Sarigiannis and 
Hansen 2012).These CRA methodologies have been used in various contexts. For example, 
Wolansky and co-workers derived relative potency factors for 11 pyrethroids after an acute 
exposure in rats, based on the prolongation of the open state of sodium channels (Wolansky 
et al., 2005). Similarly, in 2002 and 2006, the US EPA proposed a CRA approach for 30 
organophosphate pesticides based on brain cholinesterase inhibition in rats after exposure 
of21 days or longerviaoral, dermal or respiratoryroutes. RPFs were determined according to 
their respectivebenchmark dose(US EPA, 2006, 2002).In 2011 the same approach was 
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suggested to assess the risk related to exposure to a mixture of phthalates during pregnancy, 
based on a decrease in testosterone production and alteration of gene expression by fetal 
testes (Hannas et al., 2011).In 2013, Jensen and co-workerspublished a cumulative risk 
assessment for 4 anti-androgenic fungicides belonging to different chemical classes 
(triazoles, imidazoles, dicarboximides). They used the RPF approach based on benchmark 
dose calculation to assess two effects (increased gestation period in pregnant females and 
increased nipple retention in male offspring)(Jensen et al., 2013). 
In the case of situations where toxicological data are complete, with a deeper understanding 
of mechanisms and modes of action, it is possible to refine CRA by using toxicokinetic 
interactions and internal doses at the target site of action (Haddad et al., 2001). Taking into 
account the toxicokinetic interactions was also developed by Sarigiannis and co-workers. 
they used a physiologically-based pharmacokinetic model to assess the internal dose of 
benzene following a co-exposure to four volatile organic compounds (benzene, toluene, 
ethylbenzene and xylene). These authors showed that benzene cancer risk estimate calculated 
from the combined exposure was lower than risk from benzene exposure alone. This was due 
to a metabolic competition (Sarigiannis and Gotti, 2008). 
If these methods should be developed in the future, as it was suggested by the authors 
(Sarigiannis et al., 2009), these situations where mechanistic data are understood are 
unfortunately still too rare and it is not possible to develop this type of approach in all cases. 
 
3. An exposure-based conceptual framework 
3.1.Initial assumptions 
3.1.1. The concept of dose addition 
The concept of dose addition is a long-established concept suggested in the risk assessment 
process to take into account chemicals with a common mode of action, in which it is assumed 
that each component in the mixture acts as if it were a simple dilution of another one. The 
fundamental assumption is that each chemical in a mixture exhibits a common toxic mode of 
action. Typically, it would be necessary to know all toxicokinetic data and biochemical and 
molecular pathways for each compound in order to verify this concept. But biochemical 
interactions (absorption, compounds-cell interactions) cannot be known for all possible 
mixtures and all given situation, which is why a pragmatic approach was finally 
recommended for risk assessment. This concept is recommended for CRA processes by 
7 
 
several organizations as a default approach for decision making when no data prove the 
contrary (European Commission, 2012; US EPA, 2010, 2002, 2000, 1986; WHO/IPCS, 
2009), based on the fact that interactions between chemicals are unlikely to occur at 
environmentally relevant concentration(SCHER, 2007). The dose addition concept has also 
been observed for some mixtures. In 2008, Howdeshelland co-workersvalidated this concept 
for a mixture of five phthalate esters able to inhibit fetal testicular testosterone production in 
rats(Howdeshell et al., 2008). In 2009, other authors validated the same hypothesis, finding 
that the combined effects of a mixture of four anti-androgens from different chemical 
families were dose additive (for changes in ano-genital distance, retained nipples and sex 
organ weights). Nevertheless, they also observed synergistic effects on malformations of 
external sex organs (Christiansen et al., 2009). In 2012, Christen and co-workers showed that 
this dose-additivity concept is appropriate to assess themixture effect of antiandrogenic 
phthalates and bisphenol A(Christen et al., 2012). They also showed a tendency to synergism 
at high concentrations and antagonism at low concentrationsaccording to the model and the 
compound mixtures selected  The authors explain thesedeviations from the dose-additivityby 
the mechanism of interaction at the androgen receptor (binding site and strength) rather than a 
toxicokinetic interaction. According to Evans and co-workers(Evans et al., 2012), these 
deviations can be explained by the type of chemical tested, the number of compounds in the 
mixture, and the design of the study. The authors designed experiments using mixtures of 
pollutants(plasticizers, phthalates, metals, PCBs, phytoestrogens, PAHs, heterocyclic amines, 
antioxidants, UV filters, musks, PBDEs and parabens) that address these factors. The first 
one was a “balanced” mixture with components present in proportion to a common effect 
concentration. The second one was a “non-balanced” mixture with components in proportion 
to potential human tissue concentrations. The second part of their study consistedof testing 
the individual and simultaneous ability of 16 potential modulator chemicals to influence the 
assay outcome produced by a reference mixture of chemicals.They concluded that the dose-
additivity concept commonly provides a good prediction of mixture effects. 
 
3.1.2. Atrans-family multi-pollutant approach  
The selection of compounds is a critical step of in CRA. It would make sense to 
groupchemicals on the basis of chemical similarities because of dose additivity, but in real 
life situations, people are exposed toa variety of pollutants from different chemical families. 
This issue needs to be addressed,as pointed out by Sexton and Hattis in 2007 (Sexton and 
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Hattis, 2007). In the framework we propose, the chemicals to be included in the CRA should 
not be limited to onechemical family (e.g. phthalates) or onechemical use (e.g. fungicides) 
but should be selected based on observed exposures or environmental contaminations. 
 
3.1.3. Data availability 
The risk assessment approach is currently used to address health risk policy issues related to 
environmental contaminants when epidemiological data are insufficient to establish causal 
relationships and calculate attributable risks to humans. The process has been defined by the 
US General Accounting Office as “a systematic, scientific description of potential adverse 
effects of exposures to hazardous substances or situations” and “a complex but valuable set of 
tools helping agencies to identify issues of potential concern, select regulatory options and 
estimate the range of a forthcoming regulation’s benefit”(US GAO, 2001). Thus the main 
objective of a risk assessment approach is to assist policymakersin the decision-making 
process.Because the risk assessment process is implemented even if scientific data are 
lacking, a number of default assumptions are usually applied.A default option has been 
defined by the NRC as “the option chosen on the basis of risk assessment policy that appears 
to be the best choice in the absence of data to the contrary” (National Research Council, 
1983). The main assumptions involve the value of using animal data to assess the risk in 
humans (same types of effects expected in both species), the use of a threshold approach for 
non-carcinogenic or non-genotoxic carcinogenic chemicals and the idea that humans are 
more vulnerable than laboratory animals. In the case of a CRA with a threshold approach, 
dose-additivity is also a default assumption. If new data becomes available, the default 
assumptions are not taken into account and the risk assessment process shouldbe more 
accurate leading to less conservative conclusions. 
 
3.2.Structuring the hazard identification of the CRA 
For a given situation, usingactualexposures for a CRArequiresa comprehensive view of 
pollutants, i.e.selecting pollutantsfrom a large variety. This isthe firstsub-step of hazard 
identificationin exposure-based CRA. In the second sub-step, the effects,modes and 
mechanisms of action of all the detected compounds are identified. In the last sub-step,the 
pollutants are grouped according to their similarity of action on the organism. At the end of 
these three sub-steps, the dose response assessment consists inderiving multi-pollutant 
toxicity reference values for each exposure situation, leading to the last two steps of the 
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conventional approach, i.e. exposure assessment and risk characterization. The framework is 
presented in Table 1. Each of the 3 sub-steps is described below. 
 
3.2.1. Identification of pollutants people are exposed to 
This identification of pollutants people are exposed to can rely on human biological 
monitoring and/or on environmental monitoring. These data can originate from 
biomonitoring programs (NHANES, 2013; Schulz et al., 2007), from total diet studies(Arnich 
et al., 2012)orfrom environmental studies in general, indoor or particular environment (Lucas 
et al., 2012; Mompelat et al., 2011; Rudel and Perovich, 2010). Main limitations at this step 
are related to false negative (a pollutant is not identified although it should be).The presence 
of false negatives may be due to high limits of detection or by the transformation of the 
parent compoundinto unknown metabolites – in the environment or in the body. 
 
3.2.2. Identification of effects, modes and mechanisms of action 
From a biological point of view, an effect due to exposure to one or more pollutants is caused 
by a series of mechanisms of action or “key-events”, defined by Boobisand co-workersas 
measurable events that are critical to the induction of the effect(Boobis et al., 2008, 2006)as 
shown in figure 1.On the basis ofthisstatement, several levels of effects can be defined:   Clinical effect, which corresponds to an alteration of a body function observable by a 
clinical diagnosis. For example, alteration of cognitive or behavioral functions, such 
as hyperactivity or attention-deficit, could be diagnosed based on standardized 
testslike the Behavior Assessment Systems for Children;   Impairment of the target organ. The clinical effect previously described is usually 
induced by an effect on an organ. For example, in the case of behavioral impairment, 
the effect on a target organ could be an alteration of the thyroid or the brain;  Effect at a cellular level: at this scale, cell damage can cause alteration of the target 
organ. These effects can be observed directly in exposed laboratory animals (after 
autopsy, microscopicobservations) or by in vitro tests (cell cultures). Examples 
include swelling, necrosis or cell death, including changes in the dendritic 
morphology of hippocampal neurons or abnormal plasticity of the synaptic junctions.  Effect at a molecular level, which corresponds to the direct interaction between the 
macromolecules responsible for cell function (proteins, aminoacids, lipids, nucleic 
acids) and the chemicals (or metabolites).A variety of intracellular mechanisms of 
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action can be disrupted. These effects are observable by in vitro tests or with high-
throughput techniques such as transcriptomics or proteomics.Examples include 
phosphorylation of the N-methyl-D-aspartate receptor or a direct interaction with the 
estrogenreceptors. These types of effects arerarelyelucidated. Nevertheless, the 
molecular consequences of these interactions can be identified, such as changes in N-
methyl-D-aspartate receptor expression, a decrease in neurotransmitters or enzymes 
levels (dopamine, etc.) or over-expression of a specific gene.In our framework, we 
consider the molecular consequence of direct interactions as an effect at a molecular 
level. 
In this step, it is important to address the biological plausibility of the effects.The mode of 
action observed in animals mustbe plausible to humans and higher plausibility is associated 
with a higher confidence level(Meek & Bucher, 2003).Thus, it is important to take into 
account the species tested (in vivo, in vitro), the window, route and duration of exposure, etc. 
Moreover, as pointed out by Borgert et al, a detailed characterization of the 
pharmacodynamics, pharmacokinetics and slope of dose response curves may be important 
criteria in evaluating whether the toxicity of a mixture can be predicted by the mode of action 
of its component chemicals (Borgert et al., 2004). 
 
3.2.3. Grouping pollutantsbased on similaraction 
The available information on effects, modes and mechanisms of action for each pollutant 
canbe gathered into a unique dendrogram recapitulating the 4 levels of effects (clinical, 
organic, cellular, and molecular). Figure 2 describes this framework that groups information 
according to theselevels. Pollutants inducing the same effects on organisms or having the 
same mechanism of action at a cellular and molecular level can be identified and grouped. 
This grouping is also a way to classify pollutants according to the availability of data. Itdrives 
the choice of a CRA method:hazard index, point of departure index, or RPF.According to the 
available information, the hazard indexor the point of departure indexapproachescan be used 
when we have information only on a clinical effect (e.g.reduced fertility, behavioral changes) 
or a target organ or cell, depending on the application of uncertainty factors (for each 
pollutant or for the mixture). When the mechanism of action is known (e.g. binding to a 
receptor) or the consequence of this mechanism of action is known (e.g. decreased protein 
synthesis),an RPF approachcan be used. 
This exposure-based CRA framework was tested on a case study presented below. 
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4. Case study: semi-volatile organic compounds in French indoor environments 
4.1.Context 
Semi-volatile organic compounds (SVOCs) such as phthalates, PBDEs and PCBs are 
ubiquitous in indoor environments because of the increasing use of new materials and 
substances (pesticides, plasticizers, flame retardants, preservatives) (Mercier et al, 2011)and 
most of them are considered as endocrine disruptors (Rudel and Perovich, 2010).Due to their 
physicochemical properties, SVOCs partition betweenair, airborne particles, surface and 
settled dust, making them easily bioaccessible, whether viarespiratory, oral or dermal routes. 
Children are particularly vulnerable to exposure (vulnerable biological systems and 
vulnerable behavior with hand-to-mouth activity).  
 
4.2. Step 1a: Pollutant identification based on real exposures 
A list of SVOCs was prioritized on the basis of their contamination and toxicity levels 
(Bonvallot et al, 2010). Nationwide sampling campaigns were carried out in French 
dwellingsto characterize the contamination of indoor air and settled dust by more than 55 
SVOCs (Blanchard et al., 2011; Glorennec et al., 2011)measured together in a specific multi-
residue analysis(Mercier et al., 2011; 2012). For CRA, we selected the SVOCswith 
concentrations in air or settled dust above the limit of quantificationin more than 25% of 
dwellings, on the basis of preliminary results (n=235). We identified21 SVOCsout of 55 
measured including 8 phthalates (di(2-ethylhexyl)phthalate (DEHP), dibutyl phthalate (DBP), 
di-isononyl-phthalate (DiNP), di-isobutyl-phthalate (DiBP), bentyl benzyl phthalate (BBP), 
di-ethyl phthalate (DEP), bis(2-methoxyethyl)phthalate (DMEP)anddi-methyl phthalate 
(DMP)), 4 PBDEs (BDE-47, -99, -100 and-209), 3 pesticides (lindane, permethrin and 
cypermethrin),3 PCBs (PCB-101, -138 and -153), 2 musks (galaxolide andtolanide) and 
bisphenol A (BPA). 
 
4.3. Step 1b: Hazard identification, effects and mechanisms of action 
Hazard identification of the 21 SVOCs was performed by means of a literature review  
focusing on two well-documented systems: the reproductive and nervous systems. Selection 
criteria included the description of mechanism of action of these SVOCs, and the description 
of the target organs/cells. When there were a great many articles, priority was given to the 
most recent ones. 
 
4.3.1. Reprotoxic effects 
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According to the time of exposure (pre or post-natal), some SVOCs may induce 
malformations of the genital tract orreducedfertility (alteration of sperm production) in 
mammals due to their impact on Leydig and Sertoli cells. Different mechanismsof action 
have been suggested: inhibition of insulin-like 3(INSL3) 
synthesis;decreasedsteroidogenicenzyme levels (StAR, P450scc),leading to decreased 
testosterone synthesis;inhibition ofFollicle-Stimulating Hormone (FSH) action, leading to 
inhibition of Androgen Binding Protein (ABP) and/or inhibinα (INHα) synthesis andstopping 
Sertoli cell proliferation;induction of ROS production, leading to the death of Sertoli cells; 
inhibition ofconnexin 43 (protein acting as a link between Sertoli and germ cells) with a 
release of Fas-L death signal. Reduced female fertility due to lower aromatase activity, and 
higher testosterone, androstenedione and progesterone secretionwas also observed (see 
Supplemental Material, figure 3). 
 
4.3.2. Neurotoxic effects 
Twelve of the 21 selected SVOCs act on the nervous system and are able to interfere with 
neuronal development (DEHP, BDE -47, -99, -209, BPA, PCB-101, -138, -153, lindane, 
permethrin and cypermethrin). Different modes of action were suggested: an increase in 
intracellular calcium which induces an increase of the frequency of the postsynaptic current 
and promotes the release of neurotransmitters;oxidative stress inducing neuronal apoptosis 
and a decrease in dopamine levels, inducingneurodegeneration.The selected SVOCs are also 
able to act on the thyroid in females and newborns,by inhibiting synthesis of T3 and T4 
(thyroid hormones), which are strongly involved in the nervous system and brain 
development (see Supplemental Material, figure 4). 
 
4.4.Step 1c: Grouping pollutants 
Toxicologicaldatawere tabulated indendrogramsto visualize groups of pollutants according to 
their effects or mechanisms of action for each system (reproductive and nervous) (figures 3 
and 4). This also showstheaccuracy of the available toxicologicalinformation (from target 
organ to molecular level).Five groups of pollutants were identified (Table 2)witha common 
molecular consequence of their mechanisms of action (decrease of testosterone synthesis, 
INSL3 or connexin 43 inhibition, decrease of T4 or dopamine levels). The data areaccurate 
enough to supporta hypothesis on the consequence of the molecular interaction between the 
SVOC and the organism. For these groups, aRPFapproach could be suggested. Most of these 
groups contain different chemical familiessuch as phthalates, pesticides, PCBs and PBDEs. 
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Two other groups of pollutants described in Table 3 have common cellular or clinical effects 
(neuronal cell impairment and embryotoxic effects). The data are notaccurate enoughto 
elucidate the mechanism of action. For these groups, a Point of Departure Index could be 
suggested. 
In all, considering indoor SVOCs and the reproductive and nervous systems, 7 groups of 
pollutants can be considered for a cumulative risk assessment: 5 groups for a RPF approach, 
and 2 for a point of departure index approach. They are composed of 5 to 12 pollutants from 
different chemical families in most cases. 
 
5. Discussion –Conclusion 
This framework adapted the traditional CRA approach to a trans-family multi-pollutant 
approach by taking into account data availability and actual exposures. Our proposed 
conceptual framework consists of adding a step to thetraditional cumulative risk assessment 
approach. Based on actual exposures, it groups pollutants according to their effect, on the 
basis of their mode or mechanism of action.Applying the concept to a real case allowed us to 
identify issues and to assess the value of the approach. 
This approach involves a number of important methodological issues.First, selection of 
pollutantsmust be based on criteria of interest previously defined to achieve the objective 
(frequency of quantification in our case study). During this step, we eliminated a number of 
chemicals. Second, the available information varies according to the body system studied, 
since there is more mechanistic information onpollutants affecting reproduction than for other 
systems. The RPF approach wouldtherefore be easier to implement for reproductive effects. 
From a mechanistic point of view, the system for which there is the least information is the 
immune system. For this system, a point of departure indexapproach is likely to be promoted, 
emphasizing effects rather than mechanisms. The case study also illustrated that there is a 
trade-off between the number of pollutants we wish to consider and the accuracy level for 
dose-additivity. Indeed, because of the accuracy of available information, the more pollutants 
we want to include, the less likely it is that the RPF approach can be used. Third, uncertainty 
plays an important role in risk assessment. In the case of pollutants grouping for CRA 
approaches, the main sources of uncertainty include the selection of compounds (no pollutant 
must be neglected) and the knowledge of mechanisms or modes of action, which is 
fragmented. Nevertheless, the use of this approach provides a wider perspective on human 
health risks and results in a lower uncertainty than the traditional risk assessment. 
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Finally, this case study demonstrated the value of an exposure-based CRA, as we determined 
that pollutants with similar effects or mechanisms of action donot all belong tothe same 
chemical family.The approach has also been shown to befeasiblealthough the greatest 
limitation is its dependence on the availability of toxicological data. 
In conclusion, the proposed methodology for creating groups of substances with the same 
targets and modes or mechanisms of action can formthe basis for exposure-based cumulative 
risk assessment for many situations with complex exposures. The main challenge is still to 
generate toxicological – or epidemiological – data on the largest possible number of 
pollutants that are relevant to human exposure. 
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Table 1:Comparison of the proposed exposure-based cumulative risk assessment framework 
with the conventional cumulative risk assessment. 
 
Conventional CRA approach Exposure-based CRA approach 
1. Hazard identification 
1a. Identification of pollutants people are 
exposed to 
1b. Hazard identification: effects and 
mechanisms of action of each pollutant 
1c. Grouping of pollutants with similar 
effects and/or mechanisms of action 
2. Selection of toxicity reference values  
2. Derivation of “multi-pollutant”toxicity 
reference values 
3. Exposure assessment 
4. Risk characterization 
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Table 2: Groups of semi volatile organic compounds (SVOCs)for which the relative potency 
approach is suggested 
 
Groups 
of 
SVOCs 
Description Clinical effects 
Cellular 
effects 
Mechanisms 
Group A  
DEHP, DiNP, DiBP, 
BBP, DEP, BDE 47, BDE 
99, BDE 100, 
BPA,lindane,permethrin, 
cypermethrin 
Reproduction impairment: 
Depending on the window 
of exposure: decrease in 
sperm quality or 
hypospadias 
Leydig cell 
impairment 
Decrease of 
testosterone 
synthesis by 
decrease of 
steroidogenic 
enzymes levels 
Group B 
DEHP, DBP, DiNP, 
DiBP, BBP 
Reproduction impairment: 
Cryptorchodism only if 
prenatal exposure 
Leydig cell 
impairment 
INSL3 inhibition 
Group C 
DEHP, DBP, DiNP, 
DiBP, BBP, BPA, 
lindane, dieldrin 
Reproduction impairment: 
Decrease in sperm quality 
Sertoli and 
germ cell 
detachment 
Connexin 43 
inhibition 
Group D 
BDE 47, BDE 99, BDE 
209, BPA, PCB 101, PCB 
153, lindane, permethrin, 
cypermethrin 
Nervous system:  
possible 
neurodegeneration 
Thyrocyte 
cell 
impairment 
Decrease of 
thyroxine (T4) 
levels 
Group E 
BPA, PCB 101, PCB 153, 
lindane, permethrin, 
cypermethrin 
Nervous system: 
 possible 
neurodegeneration 
Neuronal 
cell 
impairment 
Decrease of 
dopamine levels 
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Table 3: Groups of semi volatile organic compounds (SVOCs)for which the point of 
departure indexapproach is suggested 
  
Group of 
SVOCs 
Description Clinical effects 
Cellular 
effects 
Mechanisms 
Group F 
BDE 47, BDE 99, BDE 
100, BDE 209, BPA, PCB 
101, PCB 138, PCB 153, 
lindane, permethrin, 
cypermethrin 
Nervous system: 
Neurodegeneration  
Neuronal 
cell 
impairment 
? 
Group G 
DEHP, DBP, DMEP, 
BPA,lindane 
Reproduction: 
Embryotoxic, fetotoxic 
and/or teratogenic 
effects 
? ? 
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Figure 1: Effect of pollutants at different body scales 
We are exposed, via different routes, to a number of pollutants which penetrate the body and 
reach the cells of target tissues and organs. Key molecular events are responsible for organic 
dysfunction affecting the exposed population. 
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Figure 2: Suggested way of presenting toxicologicalinformation in a cumulative risk 
assessment 
Traditionally, the hazard index approach is used to assess the health risk of a substance. The 
point of departure index approach is used when more accurate information (physiological 
effect, target organ or target cells) is available. The Relative Potency Factor (RPF) approach 
is used when even more accurate information (mode or mechanism of action) is available.  
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Figure 3: Mechanisms of action and toxic effects of selected indoor semi volatile organic 
compounds (SVOCs)on the reproductive system 
15 pollutants act at different levels of the reproductive system. This dendrogramshowsthe 
accuracy of the information for each one.It allows us to identifythose acting together at 
different scales of this system, which can be grouped to determine toxicityreference values. 
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Figure 4: Mechanisms of action and toxic effects of selected indoor semi volatile organic 
compounds(SVOCs) on the nervous system 
12 pollutants act at different levels of the nervous system. This dendrogramshowsthe 
accuracy of the information for each one. It allows us to identify those acting together at 
different scales of this system, which can be grouped to determine toxicityreference values. 
 
 
